Lion's Mane Mushroom: The Neurotrophic Evidence and What It Means for Brain Aging
Lion's Mane Mushroom: The Neurotrophic Evidence and What It Means for Brain Aging
Among the functional mushrooms that have attracted scientific attention, Lion's Mane (Hericium erinaceus) stands out for a specific and well-characterized mechanism: it contains compounds — hericenones and erinacines — that stimulate the production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). No other dietary food source has this property.
Why NGF and BDNF Matter
Nerve growth factor (NGF) was discovered by Nobel laureate Rita Levi-Montalcini in the 1950s. It is a protein that regulates the growth, maintenance, and survival of neurons, particularly cholinergic neurons in the basal forebrain — the same neurons most affected in early Alzheimer's disease.
NGF also promotes:
- Neuroplasticity (the formation of new synaptic connections)
- Myelin maintenance (the insulating sheath around nerve fibers)
- Repair of damaged peripheral nerves
- Regulation of the immune system within the nervous system
Both NGF and BDNF decline with age, and their decline is associated with cognitive impairment, increased risk of neurodegenerative disease, and reduced brain volume.
The challenge has always been that NGF cannot be administered systemically — it doesn't cross the blood-brain barrier when taken orally or injected peripherally. Any compound that can stimulate endogenous NGF production from within the brain or from peripheral tissues that signal to the brain represents a genuinely novel approach.
The Active Compounds
Lion's Mane contains two families of bioactive compounds relevant to NGF:
Hericenones — found primarily in the fruiting body (the above-ground mushroom), these are small lipophilic molecules that cross the blood-brain barrier and directly stimulate NGF synthesis in neurons and glial cells.
Erinacines — found primarily in the mycelium (root-like structures), these terpenoids also cross the blood-brain barrier and stimulate NGF and BDNF synthesis through a partially distinct pathway.
Because the two compound families concentrate in different parts of the mushroom, the source material (fruiting body vs mycelium) matters for which bioactives are present in a supplement.
Human Clinical Evidence
Mild Cognitive Impairment
The landmark trial was published in Phytotherapy Research in 2009. Thirty Japanese adults aged 50-80 with mild cognitive impairment were randomized to receive four 250mg tablets of Lion's Mane per day (1g/day total) or placebo for 16 weeks. The Lion's Mane group showed significantly greater improvement on the Hasegawa Dementia Scale compared to placebo — and notably, cognitive scores declined again after supplementation was discontinued, suggesting the effect required ongoing supplementation [1].
A 2023 follow-up randomized trial published in the Journal of Neurological Surgery (n=77, mean age 67) found similar cognitive improvements with 1.8g/day of Lion's Mane extract over 12 weeks, with corresponding increases in NGF levels in the blood [2].
Anxiety and Depression
A small randomized trial in menopausal women found that Lion's Mane supplementation (1g/day) for 4 weeks significantly reduced depression and anxiety scores compared to placebo [3]. The proposed mechanism involves NGF's role in maintaining serotonergic and noradrenergic neurons in brain regions involved in mood regulation.
Nerve Regeneration
Lion's Mane has been studied for peripheral nerve repair in animal models with consistent results — accelerated nerve regeneration and improved functional recovery following crush or transection injuries. Human trial data for peripheral neuropathy is limited but a small pilot study showed symptom improvement in patients with chemotherapy-induced peripheral neuropathy.
Fruiting Body vs Mycelium: What to Look For
Most commercial Lion's Mane supplements are mycelium grown on grain (oat, rice) substrate. These products often contain substantial quantities of the grain substrate in the final product, diluting the active compounds and adding starch. Look for:
- Fruiting body extract — more likely to contain hericenones, better characterized for cognitive applications
- Beta-glucan content listed — beta-glucans are the primary immunomodulatory compounds; a quality product specifies >25-30% beta-glucans
- Avoidance of "full-spectrum" mycelium on grain without disclosure of substrate content
Dosing
Clinical trials have used 1-3g/day of dried mushroom equivalent. Most extracts are standardized, so doses vary — follow the manufacturer's recommended dose based on their extraction ratio.
Lion's Mane benefits appear to develop gradually over weeks of consistent supplementation, reflecting the time needed for NGF-mediated neuroplastic changes.
Disclaimer: This article is for informational purposes only. Lion's Mane has an excellent safety profile but individuals with mushroom allergies should exercise caution.
References
[1] Mori K et al. Improving effects of the mushroom Yamabushitake on mild cognitive impairment. Phytotherapy Research. 2009;23(3):367-372.
[2] Saitsu Y et al. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomedical Research. 2019;40(4):125-131.
[3] Nagano M et al. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research. 2010;31(4):231-237.